A diorganotin( iv ) hydrazide complex as a potential cancer chemotherapeutic agent targeting DNA using the carrier protein HSA.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: